Serotonin is not synthesized, but specifically transported in the neurons of the hypothalamic dorsomedial nucleus

The European Journal of Neuroscience
S Vanhatalo, S Soinila


A small group of neurons in the hypothalamic dorsomedial nucleus (DMN) have been reported to contain serotonin after pharmacological treatments enhancing brain serotonin levels. This study aimed at elucidating whether these neurons are able to synthesize serotonin de novo, and whether they possess a specific serotonin transport mechanism. Serotonin content in these neurons was raised by administration of L-tryptophan and pargyline. Double immunostaining for serotonin and tryptophan hydroxylase (TpOH), the serotonin synthesizing enzyme, revealed that none of the serotonin-containing neuronal somata expressed TpOH. Intracerebroventricular colchicine treatment did not result in TpOH-IR in these neurons. Fluoxetine, a specific serotonin transport inhibitor, prevented the accumulation of serotonin in these neurons. The present results thus indicate that the serotonin-containing DMN neurons are not able to synthesize serotonin. Instead, they take up exogenous serotonin via a specific serotonin transport mechanism. As serotonin and DMN are associated with various physiological functions, such as regulation of food intake and modulation of fear and anxiety, the mechanisms revealed in the present study may participate in these clinicall...Continue Reading


Aug 31, 2011·Invertebrate Neuroscience : in·Sagar JhalaPaul S Katz
Dec 2, 2008·Biological & Pharmaceutical Bulletin·Tomokazu ShinozakiToshiaki Shibasaki
Jun 17, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Gholamali JafariJi Ying Sze
Jun 4, 2011·Journal of Chemical Neuroanatomy·Christina Lillesaar
Jan 11, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Audrey Franceschi BiagioniN C Coimbra
Jun 30, 2009·Journal of Chemical Neuroanatomy·Cristiane MeneghelliJosé Marino-Neto
Jan 1, 1999·Nutritional Neuroscience·S Vanhatalo, S Soinila
Mar 12, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Holger KittnerPeter Illes


Apr 1, 1978·Clinical Pharmacology and Therapeutics·L LembergerD Wong
Jun 1, 1990·Brain Research. Developmental Brain Research·D BecquetM Hery
Jan 1, 1992·Physiological Reviews·B L Jacobs, E C Azmitia
Dec 1, 1990·Pharmacology, Biochemistry, and Behavior·S F LeibowitzJ S Suh
Nov 1, 1986·Brain Research Bulletin·S SchimchowitschG Pelletier
Jan 1, 1987·Annual Review of Neuroscience·P J Marangos, D E Schmechel
Oct 1, 1987·Neuroscience·D WeissmannJ F Pujol
Jun 1, 1984·Brain Research Bulletin·T SakumotoT Maeda
Jul 1, 1984·The Journal of Comparative Neurology·P Ekström, T Van Veen
Jul 17, 1981·Neuroscience Letters·M FrankfurtE C Azmitia
May 1, 1995·International Archives of Allergy and Immunology·P W AskenaseH Matsuda
Jan 13, 1995·European Journal of Pharmacology·K PattichisV Glover
Mar 28, 1994·Neuroscience Letters·M RingkampP W Reeh
Jun 1, 1994·Pharmacology, Biochemistry, and Behavior·A ShekharJ R Simon
Jul 15, 1996·Thrombosis Research·D PawlakM Mysliwiec
Dec 1, 1995·Neuron·L SommerD J Anderson
Mar 1, 1997·Journal of the American College of Cardiology·K HermsmeyerB Greenberg
Dec 1, 1991·The Biological Bulletin·S Soinila, G J Mpitsos

Related Concepts

Serotonin Measurement
Tryptophan 5-monooxygenase
Medial Dorsal Nucleus
Set of Somas of Neurons

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.